ANTIBODY PURIFICATION: DRIVERS OF CHANGE
Technical alternatives to the standard platform approach for antibody purification are certainly emerging, but the reluctance of manufacturers to adopt them is a reflection of the conservatism in our industry. This conservatism is driven by two factors—the regulatory burden of making changes and whe...
Saved in:
Published in | Process Scale Purification of Antibodies pp. 699 - 716 |
---|---|
Main Authors | , , |
Format | Book Chapter |
Language | English |
Published |
United States
John Wiley & Sons, Incorporated
2017
John Wiley & Sons, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Technical alternatives to the standard platform approach for antibody purification are certainly emerging, but the reluctance of manufacturers to adopt them is a reflection of the conservatism in our industry. This conservatism is driven by two factors—the regulatory burden of making changes and whether a new technology/approach fits within existing facility designs. This chapter focuses on some of the topics that influence change and may facilitate the stepwise incorporation of improvements. These include, but are not limited to, the changing regulatory environment, coupled with the ever‐increasing ability (and requirement) to generate data, the emergence of innovative technology, process economics, the globalization of our industry, and finally follow‐on biologics (FOBs). Ultimately, the continued evolution of antibody purification will be a function of the continued popularity of antibodies as a therapeutic modality. |
---|---|
ISBN: | 9781119126911 1119126916 |
DOI: | 10.1002/9781119126942.ch32 |